An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in ...

Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

[28 January 2026]: Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a ...

The health reporter Kim Schewitz often feels tired, and hoped tracking her blood sugar levels using a continuous glucose ...

Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...

The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

Letitia explains how a small medical device, designed to help manage the illness, is now blamed for sending hundreds of ...

As of Friday, January 30, Senseonics Holdings, Inc.’s SENS share price has surged by 7.18%, which has investors questioning if this is right time to sell.

DexCom Inc (NASDAQ:DXCM) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. As of the ...

WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...

To request a meeting with Senseonics, investors should contact their BTIG representatives. About Senseonics Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the ...